Synthesis of flutamide-conjugates
[Display omitted] •We processed structural design and extended modification based on the flutamide structure.•A series of flutamide-conjugates were obtained with methyl bromoacetate and ethylenediamine.•The flutamide-conjugates showed good inhibition activity against HCT-15, U-251, PC-3 and K-562 ce...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2020-11, Vol.30 (21), p.127507-127507, Article 127507 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•We processed structural design and extended modification based on the flutamide structure.•A series of flutamide-conjugates were obtained with methyl bromoacetate and ethylenediamine.•The flutamide-conjugates showed good inhibition activity against HCT-15, U-251, PC-3 and K-562 cell lines.•The flutamide-conjugates did not show activity against normal monkey kidney fibroblast COS-7 cells.
In this paper, we designed and extended modification basing on the flutamide structure. A series of flutamide-conjugates were obtained with methyl bromoacetate and ethylenediamine. Through the synthesis of two conjugates with 3,5-bis(dodecyloxy)benzoate derivatives, these flutamide conjugates were tested for anticancer activity. Among the compounds tested, the flutamide-conjugates showed good inhibition activity against cancer cell lines U-251, PC-3 and K-562. The conjugates showed a better inhibitory effect than free flutamide and did not show activity against normal COS-7 monkey kidney fibroblast cells. It was also observed that the flutamide conjugates had an inhibitory effect against human colorectal adenocarcinoma HCT-15. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2020.127507 |